Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Avivagen Inc V.VIV

Alternate Symbol(s):  VIVXF

Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.


TSXV:VIV - Post by User

Bullboard Posts
Comment by Ibuyvalueon May 04, 2018 4:51pm
64 Views
Post# 27985411

RE:Management Shares/Options

RE:Management Shares/OptionsThe “going concern” statement on the NRs is just typical Boiler Plate that all company’s without Profits, have on their NRs. 

This is not on the NR but on the financial statements! Are you saying that you should trust the Power point presentation from management over the accountant that Avivagen has to pay (obliged legally) to produce their FS. 

All i know is that they need to sell 110 Tones of  their so called disruptive 
product to brake even each year they are alive.... and they have not sold 20 tones in the last 10 years.... 

based on their stated contracts this year, they will sell about 10 tones , therefore will need to raise more capital , dilute the shareholders again, in Q4/18, if they are to be a going concern!

So far management has delivered bogus.... and they have no skin in the game. none of them has put their own savings into the co. 

Why should you trust these guys with their empty promises ?






Bullboard Posts